Related Experiment Video
Updated: Jul 11, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Atherosclerosis and Its Related Laboratory Biomarkers
Vittoriano Della Corte1, Federica Todaro1, Marco Cataldi1
1Internal Medicine and Stroke Care Ward, Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialities (ProMISE) "G. D'Alessandro", University of Palermo, Piazza delle Cliniche n.2, 90127 Palermo, Italy.
Insights
This review examines novel serum biomarkers for atherosclerosis, a chronic inflammatory disease. Identifying these markers can improve cardiovascular risk prediction and clinical decision-making for conditions like coronary artery disease.
Area of Science:
- Cardiovascular Medicine
- Biomarker Discovery
- Inflammatory Diseases
Background:
- Atherosclerosis is a chronic inflammatory condition underlying major cardiovascular diseases (CVDs) such as coronary artery disease (CAD) and peripheral artery disease (PAD).
- Plaque accumulation in arteries narrows vessels, impeding blood flow and causing tissue hypoxia, which can lead to stroke and myocardial infarction—leading global causes of mortality.
- Current cardiovascular risk prediction models rely on conventional risk factors but may benefit from incorporating novel biomarkers.
Purpose of the Study:
- To conduct a comprehensive review of recent literature on serum biomarkers associated with atherosclerosis.
- To evaluate the potential of these biomarkers in enhancing the accuracy of cardiovascular risk prediction models.
- To explore the clinical utility of incorporating novel biomarkers in guiding patient management decisions.
Main Methods:
- Systematic literature search of recent publications on serum biomarkers for atherosclerosis.
- Analysis of studies investigating the predictive value of individual and combined biomarkers.
- Evaluation of biomarker integration into existing cardiovascular risk assessment frameworks.
Main Results:
- Numerous serum biomarkers linked to increased atherosclerotic event risk have been identified.
- The inclusion of certain biomarkers, individually or in panels, shows potential to improve the predictive accuracy of cardiovascular risk models.
- Further research is needed to fully elucidate the clinical utility and optimal application of these novel markers.
Conclusions:
- Serum biomarkers represent a promising area for advancing atherosclerosis risk assessment.
- Integrating validated biomarkers into clinical practice could refine cardiovascular risk stratification and personalize patient care.
- Continued research into biomarker validation and clinical implementation is crucial for improving outcomes in patients with or at risk for atherosclerotic diseases.
Abstract:
Atherosclerosis constitutes a persistent inflammatory ailment, serving as the predominant underlying condition for coronary artery disease (CAD), peripheral artery disease (PAD), and cerebrovascular disease. The progressive buildup of plaques within the walls of medium- and large-caliber arteries characterizes the atherosclerotic process. This accumulation results in significant narrowing that impedes blood flow, leading to critical tissue oxygen deficiency. Spontaneous blockage of thrombotic vessels can precipitate stroke and myocardial infarction, which are complications representing the primary global causes of mortality. Present-day models for predicting cardiovascular risk incorporate conventional risk factors to gauge the likelihood of cardiovascular events over a ten-year span. In recent times, researchers have identified serum biomarkers associated with an elevated risk of atherosclerotic events. Many of these biomarkers, whether used individually or in combination, have been integrated into risk prediction models to assess whether their inclusion enhances predictive accuracy. In this review, we have conducted a comprehensive analysis of the most recently published literature concerning serum biomarkers associated with atherosclerosis. We have explored the potential utility of incorporating these markers in guiding clinical decisions.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology

